TrialAntimicrobial agents and chemotherapy2016

Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239.

Christopher M Owens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.